DB
CBPO

Dmitry Balyasny’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Dmitry Balyasny’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-7,100
Closed -$655K – 2529
2017
Q3 		$655K Buy
+7,100
New +$682K ﹤0.01% 1267

Other funds holding CBPO

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return

Dmitry Balyasny's CBPO Position: Q4 2017 in Review

Dmitry Balyasny sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2017, closing a stake of 7,100 shares — an estimated $655K sold.

Dmitry Balyasny first reported a position in CBPO in Q3 2017 and held it in 1 quarter. The position peaked at $655K in Q3 2017. 93 funds tracked by Wall St. Rank hold CBPO as of Q4 2017.

  • Dmitry Balyasny reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2017 after selling out during the quarter.
  • Dmitry Balyasny sold 7,100 China Biologic Products Holdings, Inc. shares in Q4 2017, an estimated $655K.
  • Dmitry Balyasny first reported a position in China Biologic Products Holdings, Inc. in Q3 2017 and held it in 1 quarter.
  • Dmitry Balyasny's China Biologic Products Holdings, Inc. position peaked at $655K in Q3 2017.
  • 93 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2017.

Based on Balyasny Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.